Page 193 - Read Online

Kaufman et al. J Cancer Metastasis Treat 2019;5:13 I http://dx.doi.org/10.20517/2394-4722.2018.25 Page 9 of 10

13. Teixeira N, Mourits MJ, Vos JR, Kolk DM, Jansen L, et al. Ovarian cancer in BRCA1/2 mutation carriers: the impact of mutation position
and family history on the cancer risk. Maturitas 2015;82:197-202.
14. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med 2017;14:9-32.
15. Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: a report from the health disparities
taskforce of the society of gynecologic oncology. Gynecol Oncol 2014;133:353-61.
16. Srivastava SK, Ahmad A, Miree O, Patel GK, Singh S, et al. Racial health disparities in ovarian cancer: not just black and white. J Ovarian
Res 2017;10:58.
17. Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, et al. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Obstet Gynecol 2013;122:1025-32.
18. Bownes LV, Stafman LL, Maizlin II, Dellinger M, Gow KW, et al. Socioeconomic disparities affect survival in malignant ovarian germ cell
tumors in AYA population. J Surg Res 2018;222:180-6.
19. Sakhuja S, Yun H, Pisu M, Akinyemiju T. Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality
among Blacks and Whites. J Ovarian Res 2017;10:57.
20. Cragun D, Weidner A, Lewis C, Bonner D, Kim J, et al. Racial disparities in BRCA testing and cancer risk management across a population-
based sample of young breast cancer survivors. Cancer 2017;123:2497-505.
21. Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, et al. Risk assessment, genetic counseling, and genetic testing for BRCA-
related cancer in women: a systematic review to update the U.S. Preventive Services Task Force Recommendation. Ann Intern Med
2014;160:255-66.
22. Eccles DM, Mitchell G, Monteiro AN, Schmutzler R, Couch FJ, et al. BRCA1 and BRCA2 genetic testing- pitfalls and recommendations
for managing variants of uncertain clinical significance. Ann Oncol 2015;26:2057-65.
23. Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci 2017;151:1-32.
24. Jones T, McCarthy AM, Kim Y, Armstrong K. Predictors of BRCA1/2 genetic testing among black women with breast cancer: a population-
based study. Cancer Med 2017;6:1787-98.
25. Churpek JE, Walsh T, Zheng Y, Moton Z, Thornton AM, et al. Inherited predisposition to breast cancer among African American women.
Breast Cancer Res Treat 2015;149:31-9.
26. Ricks-Santi L, McDonald JT, Gold B, Dean M, Thompson N, et al. Next generation sequencing reveals high prevalence of BRCA1 and
BRCA2 variants of unknown significance in early-onset breast cancer in African American women. Ethn Dis 2017;27:169-78.
27. Bandera EV, Lee VS, Rodriguez-Rodriguez L, Powell CB, Kushi LH. Racial/ethnic disparities in ovarian cancer treatment and survival.
Clin Cancer Res 2016;22:5909-14.
28. Bandera EV, Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, et al. Obesity, weight gain, and ovarian cancer risk in African American
women. Int J Cancer 2016;139:593-600.
29. Chatterjee S, Gupta D, Caputo TA, Holcomb K. Disparities in gynecological malignancies. Front Oncol 2016;6:36.
30. Liu Z, Zhang TT, Zhao JJ, Qi SF, Du P, et al. The association between overweight, obesity and ovarian cancer: a meta-analysis. Jpn J Clin
Oncol 2015;45:1107-15.
31. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, et al. Obesity and the risk of epithelial ovarian cancer: a systematic review
and meta-analysis. Eur J Cancer 2007;43:690-709.
32. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of
U.S. adults. N Engl J Med 2003;348:1625-38.
33. Choi EK, Park HB, Lee KH, Park JH, Eisenhut M, et al. Body mass index and 20-specific cancers: re-analyses of dose-response meta-
analyses of observational studies. Ann Oncol 2018;29:749-57.
34. Clarke P, O'Malley PM, Johnston LD, Schulenberg JE. Social disparities in BMI trajectories across adulthood by gender, race/ethnicity and
lifetime socio-economic position: 1986-2004. Int J Epidemiol 2009;38:499-509.
35. Erondu CO, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, et al. The association between body mass index and presenting symptoms
in African American women with ovarian cancer. J Womens Health (Larchmt) 2016;25:571-8.
36. Schwei RJ, Schroeder M, Ejebe I, Lor M, Park L, et al. Limited English proficient patients’ perceptions of when interpreters are needed and
how the decision to utilize interpreters is made. Health Commun 2018;33:1503-8.
37. Flores G, Abreu M, Barone CP, Bachur R, Lin H. Errors of medical interpretation and their potential clinical consequences: a comparison of
professional versus ad hoc versus no interpreters. Ann Emerg Med 2012;60:545-53.
38. Kamara D, Weil J, Youngblom J, Guerra C, Joseph G. Cancer counseling of low-income limited English proficient Latina women using
medical interpreters: implications for shared decision-making. J Genet Couns 2018;27:155-68.
39. Lee JS, Nápoles A, Mutha S, Pérez-Stable EJ, Gregorich SE, et al. Hospital discharge preparedness for patients with limited English
proficiency: a mixed methods study of bedside interpreter-phones. Patient Educ Couns 2018;101:25-32.
40. Bond J, Bateman J, Nassrally SM. The role of ad-hoc interpreters in teaching communication skills with ethnic minorities. Med Teach
2012;34:81-2.
41. Syed ST, Gerber BS, Sharp LK. Traveling towards disease: transportation barriers to health care access. J Community Health 2013;38:976-93.
42. Tan W, Stehman FB, Carter RL. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a
Gynecologic Oncology Group member treatment center: 1979-2001. Gynecol Oncol 2009;114:346-52.
43. Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract 1997;5:361-6.
44. Bristow RE, Chang J, Ziogas A, Anton-Culver H. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet
Gynecol 2013;121:1226-34.
45. Scalici J, Finan MA, Black J, Harmon MD, Nicolson W, et al. Minority participation in gynecologic oncology group (GOG) studies.
Gynecol Oncol 2015;138:441-4.
46. Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, et al. Utilization and outcomes of BRCA genetic testing and counseling in